Lawyers Reviewing Crestor Diabetes Cases

Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving Crestor. The content on this page is provided for informational purposes only.

The product liability lawyers at Saiontz & Kirk, P.A. previously reviewed potential lawsuits for former users of the popular cholesterol drug Crestor who have been diagnosed with type 2 diabetes.

Side effects of Crestor may increase the risk of diabetes and other serious health complications, yet inadequate warnings have been provided by AstraZeneca for consumers or the medical community. As a result of the drug maker’s decision to place their desire for profits before the safety of patients, financial compensation may be available through a Crestor diabetes lawsuit.

Potential cases were previously being reviewed by our Crestor lawyers on behalf of individuals throughout the United States, and there are never any fees or expenses unless a recovery is obtained for your Crestor diabetes injury.

Crestor Diabetes Problems

Crestor (rosuvastatin) is a blockbuster cholesterol drug sold by AstraZeneca, which is a member of a large class of similar drugs, known as statins.

Although Crestor was first introduced in 2003 for the limited use among patients with bad cholesterol and a history of heart disease, the FDA expanded approval in 2010 to include prescriptions for otherwise healthy individuals who may be given the drug for prevention of heart attacks, strokes and deaths.

Amid aggressive marketing and promotion, which has withheld important information about the potential risk of Crestor problems, AstraZeneca has developed one of the best selling drugs in the United States. Sales reached $6.6 billion in 2011.

Studies have identified a number of serious Crestor side effects, some of which have not been adequately disclosed on the warning label, including the risk of developing diabetes from Crestor.

In February 2012, the FDA required new Crestor warnings about the risk of the medication increasing blood sugar levels, which may cause users to become diabetic. However, numerous studies and information was available to AstraZeneca prior to this time about the potential link between Crestor and diabetes.

Crestor Lawsuit Allegations

A growing number of individuals throughout the United States are now pursuing a Crestor lawsuit against AstraZeneca, alleging that the drug maker failed to adequately research the popular cholesterol drug or warn about the potential risk of diabetes.

If adequate information had been provided, Crestor diabetes claims allege that former users could have avoided this devastating disease by taking a different medication or closely monitoring their blood sugar levels during treatments.

According to allegations raised in Crestor complaints:

  • AstraZeneca knew or should have known about the diabetes risk with Crestor, but concealed information from consumers and the medical community.
  • Neither users or doctors who prescribe the drug could have known about the potential risk of Crestor problems without adequate warnings.
  • AstraZeneca ignored available information and fraudulently concealed the risk of diabetes.
  • A Crestor recall or additional warnings should have been placed prominently on the label immediately after reports of users becoming diabetic.

In March 2004, the consumer advocacy group Public Citizen filed a petition with the FDA calling for a recall of Crestor from the market, due to the risk of severe side effects and the availability of other drugs. If accurate and complete research about the Crestor diabetes problems was disclosed earlier, it is possible that the medication never would have been approved and millions of users would not have been exposed to the potential risk of developing diabetes.

Crestor Class Action Lawyers

The Crestor lawyers at Saiontz & Kirk, P.A. previously claims for individuals throughout the United States who are now a diabetic. Crestor class action lawsuits and individual diabetes injury cases are being pursued to obtain financial compensation for health problems that may have been avoided.

All Crestor cases were reviewed under a contingency fee agreement, which means that there are no out-of-pocket costs for our Crestor attorneys to pursue your case and we receive no fees or expenses unless a recovery is obtained.

New cases are no longer being accepted by Saiontz & Kirk, P.A. This page is maintained for informational purposes only.